Pharmacokinetic analysis of docetaxel during haemodialysis in a patient with locally advanced non-small cell lung cancer [14]

Nephrology Dialysis Transplantation

Volumn 22, Issue 1, 2007, Pages 289-290

  Hochegger, Kathrin ^a   Lhotta, Karl ^a   Mayer, Gert ^a   Czejka, Martin ^b   Hilbe, Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DOCETAXEL; GEMCITABINE; PLATINUM COMPLEX;

ADVANCED CANCER; BLOOD CELL COUNT; CANCER RADIOTHERAPY; CASE REPORT; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG PROTEIN BINDING; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; LEUKOPENIA; LIQUID CHROMATOGRAPHY; LUNG NON SMALL CELL CANCER; MEDIASTINUM LYMPH NODE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SIDE EFFECT; SOLID PHASE EXTRACTION; THROMBOCYTOPENIA; TUMOR REGRESSION;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; HUMANS; KIDNEY FAILURE, CHRONIC; LUNG NEOPLASMS; LYMPHATIC METASTASIS; RENAL DIALYSIS; TAXOIDS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33846032299     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl498     Document Type: Letter

References (4)

1. Watanabe R, Takiguchi Y, Moriya T et al. Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer. Br J Cancer 2003; 88: 25-30
2. Inoue A, Saijo Y, Kikuchi T et al. Pharmacokinetic analysis of combination chemotherapy with carboplatin and etoposide in small-cell lung cancer patients undergoing hemodialysis. Ann Oncol 2004; 15: 51-54
3. Rigas JR, Lara PN,Jr. Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancer. Lung Cancer 2005; 50 [Suppl 2]: S17-S24
4. Clarke SJ, Rivory LP. Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet 1999; 36: 99-114